SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-031017
Filing Date
2022-09-06
Accepted
2022-09-06 08:11:47
Documents
14
Period of Report
2022-09-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tcon-8k_20220902.htm   iXBRL 8-K 64117
2 EX-4.1 tcon-ex41_15.htm EX-4.1 84848
3 EX-10.1 tcon-ex101_16.htm EX-10.1 620627
  Complete submission text file 0001564590-22-031017.txt   1027252

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA tcon-20220902.xsd EX-101.SCH 5611
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tcon-20220902_lab.xml EX-101.LAB 19324
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tcon-20220902_pre.xml EX-101.PRE 11504
8 EXTRACTED XBRL INSTANCE DOCUMENT tcon-8k_20220902_htm.xml XML 3564
Mailing Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122
Business Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Filer) CIK: 0001394319 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36818 | Film No.: 221226938
SIC: 2836 Biological Products, (No Diagnostic Substances)